Dronabinol Other names: (−)-trans-Δ9-tetrahydrocannabinol THC

Chemical formula: C₂₁H₃₀O₂  Molecular mass: 314.462 g/mol  PubChem compound: 16078

Active ingredient description

Dronabinol is an active ingredient of cannabis, which has complex effects on the CNS, including central sympathomimetic activity. Dronabinol exerts its action by activating CB1 and CB2 recepors which makes it a CNS active medicine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A04AD10 Dronabinol A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AD Other antiemetics
Discover more medicines within A04AD10

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 1972-08-3
DrugBank Drug: DB00470
KEGG Drug: D00306
PubChem Compound: 16078
RxNorm Ingredient: 10402
SNOMED-CT Concept: 386846008
Dronabinol (substance)
UNII Identifier: 7J8897W37S
DRONABINOL

Medicines

Dronabinol is an active ingredient of these brands:

United States (US)

Estonia (EE)

Finland (FI)

Ireland (IE)

Israel (IL)

New Zealand (NZ)

Poland (PL)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.